FallberichtOpen Access
Life-Threatening Secondary Adrenal Crisis Triggered by Pembrolizumab-Induced Hypophysitis: A Case Report
Cureus · 28.06.2026
DOI: 10.7759/cureus.111692 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 28.06.2026. Verfasst von Aye Nyein Thu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Endocrinology, Worcestershire Acute Hospitals NHS Trust, Worcester, GBR. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
autoimmune hypophysitishypogonadotrophic hypogonadismhypopituitarismimmune checkpoint inhibitors (icis)immune-related adverse events (iraes)melanomapd-1 inhibitorpembrolizumabpembrolizumab-induced hypophysitissecondary adrenal insufficiency
Autor:innen und Institutionen
- Diabetes and Endocrinology, Worcestershire Acute Hospitals NHS Trust, Worcester, GBR.
Zitieren
APA
Thu, A. N., & Babar, M. (2026). Life-Threatening Secondary Adrenal Crisis Triggered by Pembrolizumab-Induced Hypophysitis: A Case Report. Cureus. https://doi.org/10.7759/cureus.111692
Vancouver
Thu AN, Babar M. Life-Threatening Secondary Adrenal Crisis Triggered by Pembrolizumab-Induced Hypophysitis: A Case Report. Cureus. 2026. doi:10.7759/cureus.111692
BibTeX
@article{Thu2026,
author = {Thu, Aye Nyein and Babar, Munir},
title = {Life-Threatening Secondary Adrenal Crisis Triggered by Pembrolizumab-Induced Hypophysitis: A Case Report},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.111692}
}
EUVIMED